scPharmaceuticals Inc. (NASDAQ:SCPH – Free Report) – Stock analysts at HC Wainwright lowered their FY2027 EPS estimates for shares of scPharmaceuticals in a report issued on Wednesday, May 15th. HC Wainwright analyst D. Tsao now forecasts that the company will earn $1.95 per share for the year, down from their previous estimate of $2.25. HC […]

Related Keywords

, King Luther Capital Management Corp , Pharmaceuticals Daily , Rice Hall James Associates , Pharmaceuticals Company Profile , Worth Venture Partners , Pharmaceuticals Stock , Capital Management , Nasdaq , Pharmaceuticals Inc , Free Report , Get Free Report , Luther Capital Management Corp , Venture Partners , Rice Hall James , Hall James , Pharmaceuticals Company , Body Infusor ,